Adar Poonawalla, CEO of Serum Institute of India (SII), has announced that the company is working on developing a vaccine for Mpox, with expectations of a "positive outcome" within a year. This development comes in response to the global Mpox outb...
Titan Pharmaceuticals, Inc. has revealed that it is engaged in a Merger and Contribution and Share Exchange Agreement for a business merger with KE Sdn. Berhad. The board of directors of Titan approved the Merger Agreement. If Titan's and KE's...
A new scheme aimed at bolstering the domestic medical device industry will be launched within the next month, according to Arunish Chawla, Secretary of the Department of Pharmaceuticals. The scheme is currently being finalized following extensive ...
Granules India's subsidiary, Granules Pharmaceuticals Inc, has been granted approval by the US health regulator for a generic Glycopyrrolate oral solution meant for pediatric patients with neurological conditions linked to drooling. Granules India...
Gilead Sciences has collaborated with PANTHERx Rare to provide LIVDELZI, a medication aimed at adults suffering from primary biliary cholangitis (PBC). The goal of the partnership is to offer patients the specific peroxisome proliferator-activated...
Vimgreen Pharmaceuticals, a research-based pharmaceutical company specializing in adenosine signaling modulation, shared that they have finished enrolling participants in a phase 2 clinical trial for VG081821AC, a new drug for early-to-mid stage...
In July, the domestic pharmaceutical retail market witnessed a remarkable 11 percent increase. This phenomenon can be referred to as the flu impact. Increased sales of anti-infectives and pain relief suggest a rise in cases of flu and other viral...
Orchid Pharma announced a consolidated net profit of Rs. In the first quarter ending on June 30, 2024, the revenue increased by over three times to Rs 32.95 crore, exceeding the Rs 9.4 crore recorded in the same quarter of the previous fiscal...
Biosyngen, a company focused on immuno-oncology, stated that its EBV-specific CAR-T cell therapy, BRG01, has received approval from the US Food and Drug Administration (FDA) to advance into a crucial phase II clinical trial. This is the initial...
On the occasion of India's 78th Independence Day, it is a time to look back on the incredible progress and successes achieved, especially in the pharmaceutical sector. Over the years, India has become a leading player in pharmaceutical innovation...
, CDSCO.jpg)
